Ozmosi | Croscarmellose Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Croscarmellose

Alternative Names: croscarmellose
Clinical Status: Active
Latest Update: 2025-11-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Belgium | Ireland | Taiwan | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Collegium
Company Location: STOUGHTON MA 02072
Company CEO: Joseph Ciaffoni
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Croscarmellose

Countries in Clinic: Australia, Poland

Active Clinical Trial Count: 2

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Atherosclerosis|Peripheral Arterial Disease

Phase 1: Depressive Disorder, Treatment-Resistant

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ACTRN12625001326482

 ACTRN12625001326482

P1

Not yet recruiting

Depressive Disorder, Treatment-Resistant

2026-12-01

2025-11-29

Treatments

2024-511894-32-00

 CADET-PAD

P3

Not yet recruiting

Atherosclerosis|Peripheral Arterial Disease

2026-02-03

2025-05-02

Treatments

Recent News Events

Date

Type

Title

08/05/2025

News Article

 Pharmaceutical Excipients Market Size Forecasted to Surpass USD 15.43 Billion by 2034 Amid Rising Demand for Novel Drug Delivery Systems

06/06/2024

News Article

 Microcrystalline Cellulose (MCC) Market size is set to grow by USD 440.3 million from 2024-2028, Growth of the pharmaceutical industry to boost the market growth, Technavio

05/04/2024

PubMed

 3D printing of multi-unit gastro-retentive tablets for the pulsatile release of artesunate.

04/08/2024

PubMed

 Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.

02/03/2024

PubMed

 Application of Tablet in Tablet technique to design and characterize immediate and modified release tablets of Timolol maleate.

09/14/2023

News Article

 Croscarmellose Sodium Market Size, Forecasting Share and Scope for 2023-2030

09/09/2023

News Article

 Achieve Peak Wellness with SANESolution's Doctor-Endorsed Throat Cleaner

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions